Akers Biosciences Inc. (AKER)

0.42
NASDAQ : Health Technology
Prev Close 0.45
Day Low/High 0.42 / 0.46
52 Wk Low/High 0.40 / 3.92
Avg Volume 151.90K
Exchange NASDAQ
Shares Outstanding 12.50M
Market Cap 5.66M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

MONDAY DEADLINE: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Akers Biosciences, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

MONDAY DEADLINE: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Akers Biosciences, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akers Biosciences, Inc.

NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit On Behalf Of Akers Biosciences, Inc. Investors; Important August Deadline - AKER

NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit On Behalf Of Akers Biosciences, Inc. Investors; Important August Deadline - AKER

Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc.

AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER

AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER

Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc.

AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm

AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc.

AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER

AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER

Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc.

Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According To A Recently Filed Class Action

Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Akers Biosciences, Inc.

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Akers Biosciences, Inc. Investors (AKER)

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Akers Biosciences, Inc. Investors (AKER)

Law Offices of Howard G. Smith announces an investigation on behalf of Akers Biosciences, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Akers Biosciences, Inc. - AKER

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Akers Biosciences, Inc. - AKER

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Akers Biosciences, Inc.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakouts.

TheStreet Quant Rating: D- (Sell)